Citation: Ph. Maxwell et al., Insights into the role of the von Hippel-Lindau gene product - A key player in hypoxic regulation, EXP NEPHROL, 9(4), 2001, pp. 235-240
Authors:
Clifford, SC
Cockman, ME
Smallwood, AC
Mole, DR
Woodward, ER
Maxwell, PH
Ratcliffe, PJ
Maher, ER
Citation: Sc. Clifford et al., Contrasting effects on HIF-1 alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease, HUM MOL GEN, 10(10), 2001, pp. 1029-1038
Authors:
Clifford, SC
Astuti, D
Hooper, L
Maxwell, PH
Ratcliffe, PJ
Maher, ER
Citation: Sc. Clifford et al., The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1 alpha in renal cell carcinoma, ONCOGENE, 20(36), 2001, pp. 5067-5074
Authors:
Masson, N
Willam, C
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Citation: N. Masson et al., Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation, EMBO J, 20(18), 2001, pp. 5197-5206
Authors:
Epstein, ACR
Gleadle, JM
McNeill, LA
Hewitson, KS
O'Rourke, J
Mole, DR
Mukherji, M
Metzen, E
Wilson, MI
Dhanda, A
Tian, YM
Masson, N
Hamilton, DL
Jaakkola, P
Barstead, R
Hodgkin, J
Maxwell, PH
Pugh, CW
Schofield, CJ
Ratcliffe, PJ
Citation: Acr. Epstein et al., C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, CELL, 107(1), 2001, pp. 43-54
Authors:
Jaakkola, P
Mole, DR
Tian, YM
Wilson, MI
Gielbert, J
Gaskell, SJ
von Kriegsheim, A
Hebestreit, HF
Mukherji, M
Schofield, CJ
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Citation: P. Jaakkola et al., Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation, SCIENCE, 292(5516), 2001, pp. 468-472
Authors:
Vaux, EC
Wood, SM
Cockman, ME
Nicholls, LG
Yeates, KM
Pugh, CW
Maxwell, PH
Ratcliffe, PJ
Citation: Ec. Vaux et al., Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor, J BIOL CHEM, 276(47), 2001, pp. 44323-44330
Authors:
Wiesener, MS
Munchenhagen, PM
Berger, I
Morgan, NV
Roigas, J
Schwiertz, A
Jurgensen, JS
Gruber, G
Maxwell, PH
Loning, SA
Frei, U
Maher, ER
Grone, HJ
Eckardt, KU
Citation: Ms. Wiesener et al., Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas, CANCER RES, 61(13), 2001, pp. 5215-5222
Authors:
Ren, XH
Dorrington, KL
Maxwell, PH
Robbins, PA
Citation: Xh. Ren et al., Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans, J APP PHYSL, 89(2), 2000, pp. 680-686
Authors:
Wykoff, CC
Pugh, CW
Maxwell, PH
Harris, AL
Ratcliffe, PJ
Citation: Cc. Wykoff et al., Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling, ONCOGENE, 19(54), 2000, pp. 6297-6305
Authors:
Cockman, ME
Masson, N
Mole, DR
Jaakkola, P
Chang, GW
Clifford, SC
Maher, ER
Pugh, CW
Ratcliffe, PJ
Maxwell, PH
Citation: Me. Cockman et al., Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein, J BIOL CHEM, 275(33), 2000, pp. 25733-25741
Authors:
Talks, KL
Turley, H
Gatter, KC
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
Harris, AL
Citation: Kl. Talks et al., The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages, AM J PATH, 157(2), 2000, pp. 411-421
Authors:
Maxwell, PH
Wiesener, MS
Chang, GW
Clifford, SC
Vaux, EC
Cockman, ME
Wykoff, CC
Pugh, CW
Maher, ER
Ratcliffe, PJ
Citation: Ph. Maxwell et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, NATURE, 399(6733), 1999, pp. 271-275